Editorial: Mechanisms and advances in respiratory allergic diseases

Bao-Hui Cheng; Xiaojun Xiao; Yu Jin; Jing Li

doi:10.3389/fimmu.2023.1186301

Editorial: Mechanisms and advances in respiratory allergic diseases

Front Immunol. 2023 Mar 28:14:1186301. doi: 10.3389/fimmu.2023.1186301. eCollection 2023.

Authors

Bao-Hui Cheng¹, Xiaojun Xiao², Yu Jin³, Jing Li⁴

Affiliations

¹ Department of Otolaryngology, Longgang E.N.T Hospital & Shenzhen Key Laboratory of E.N.T, Institute of Ear Nose Throat (E.N.T), Shenzhen, China.
² Institute of Allergy and Immunology, Health Science Center, Shenzhen University, Shenzhen, China.
³ Department of Pathology, Yale University, New Haven, CT, United States.
⁴ Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

No abstract available

Keywords: Aspergillus fumigatus; allergic asthma; epithelial barrier dysfunction; inorganic particles; microbial dysbiosis.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Asthma* / therapy
Humans
Hypersensitivity* / therapy

Grants and funding

The present study was supported in part by the National Natural Science Foundation of China (81973915 and 81773978); Guangdong Basic and Applied Basic Research Foundation (2023A1515012207); Shenzhen Innovation of Science and Technology Commission (No. JCYJ20220531091602005 and JCYJ20200109144625016); Shenzhen Key Medical Discipline Construction Fund (No. SZXK039); Longgang Innovation of Science and Technology Commission (LGKCYLWS2022010 and LGKCYLWS2020092).